Summit Therapeutics Inc.
SMMT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001599298
No open-market purchases or sales by Summit Therapeutics Inc. insiders were filed in the last 90 days; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.98B in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Summit Therapeutics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 86 | 1 | 96 | +11 |
| Shares | 21.0M | 10.1K | 34.9M | +13.9M (+65.9%) |
| Value | $37.0M | $17.7K | $87.6M | +$50.6M (+137.0%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (35)
Institutions that held Summit Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (24)
Institutions that held Summit Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| AWM Investment Company, Inc. | 800,001 | $1.40M |
| HRT Financial LP | 397,903 | $696.0K |
| Squarepoint Ops LLC | 285,578 | $499.8K |
| Marshall Wace, LLP | 214,033 | $374.6K |
| Verition Fund Management LLC | 116,022 | $203.0K |
| Man Group plc | – | $144.6K |
| LMR Partners LLP | 64,336 | $112.6K |
| Nomura Holdings Inc | 47,971 | $83.9K |
| Schonfeld Strategic Advisors LLC | 47,617 | $83.3K |
| One68 Global Capital, LLC | 39,562 | $69.2K |
| Y-Intercept (Hong Kong) Ltd | 39,337 | $68.8K |
| Qube Research & Technologies Ltd | 34,906 | $61.1K |
| XTX Topco Ltd | 27,013 | $47.3K |
| Citadel Advisors LLC | 22,381 | $39.2K |
| Dynamic Technology Lab Private Ltd | 17,460 | $31.0K |
| Sea Otter Advisors LLC | 17,266 | $30.2K |
| Wolverine Trading, LLC | 17,738 | $29.0K |
| Q3 Asset Management | 15,761 | $27.0K |
| Diametric Capital, LP | 13,572 | $23.8K |
| Shay Capital LLC | 13,049 | $22.8K |
| Ergoteles LLC | 12,234 | $21.4K |
| Jump Financial, LLC | 11,859 | $20.8K |
| Equitec Proprietary Markets, LLC | 7,200 | $12.6K |
| Strategic Investment Solutions, Inc. | 1,000 | $1.75K |
Not filed for Q2 2023 yet (1)
Institutions that held Summit Therapeutics Inc. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| CTC Capital Management, LLC | 10,100 | $17.7K |